Clinical effect, biological background, and research priorities on n-3 fatty acids. Executive Summary.

Roberto Marchioli; G Tognoni; TD Barrington; Deepak Bhatnagar; EM Berry; Mildred M. Burr; Raffaele De Caterina; William S. Harris; Lands W Kromhout; Alison Leaf; Aldo Maggioni; Simopoulos A Nordoy; Clemens von Schacky; Reema Singh; D Siscovik; Luigi Tavazzi; Franco Valagussa

Related publications

Article2001

n-3 Polyunsaturated Fatty Acids, Fish, and Nonfatal Acute Myocardial Infarction

Alessandra Tavani, Claudio Pelucchi, Eva Negri, Michaela Bertuzzi, Carlo La Vecchia

Article2012

Erythrocyte n-3 Fatty Acids and Metabolic Syndrome in Middle-Aged and Older Chinese

Geng Zhang, Qi Sun, Frank B Hu, Xingwang Ye, Zhijie Yu, Geng Zong, Huaixing Li, Yunhua Zhou, Xu Lin

Article2012

Cardiovascular effects of B-vitamins and/or N-3 fatty acids: The Su.Fol.Om3 trial

Jacques Blacher, S. Czernichow, François Paillard, Pierre Ducimetière, Serge Hercberg, Pilar Galán

Article2009

Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial

Roberto Marchioli, Giacomo Levantesi, Maria G Silletta, Simona Barlera, Marino Bernardinangeli, Emanuele Carbonieri, Francesco Cosmi, Maria Grazia Franzosi, Roberto Latini, Donata Lucci, Aldo Maggioni, Luciano Moretti, Gian Luigi Nicolosi, Maurizio Porcu, Maria Grazia Rossi, Gianni Tognoni, Luigi Tavazzi

Letter2019

Omega-3 Fatty Acids and Heart Failure

Aldo Maggioni